Rémy Cointreau (RMC) Q2 2027 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 TU earnings summary
28 Oct, 2026Executive summary
Q2 organic sales grew 4.2%, accelerating from 1.3% in Q1; H1 sales reached €510.9m, up 2.9% organically and 4.4% reported.
Cognac and APAC led growth, offset by declines in Liqueurs & Spirits, the Americas and EMEA; full-year objectives were confirmed.
Financial highlights
H1 organic sales reflected volume down 0.4% and price/mix up 3.3%; Q2 volume rose 0.5% and price/mix increased 3.7%.
Q2 sales were €287.7m, up 7.0% reported and 4.2% organically; Group Brands grew 5.2% organically.
H1 Cognac sales were €338.7m, up 10.3% organically; Liqueurs & Spirits were €169.7m, down 7.0%, and Partner Brands were €2.5m, down 62.5%.
H1 currency translation added 1.5% to reported sales, mainly through RMB appreciation, partly offset by dollar weakness.
Outlook and guidance
FY 2026-27 guidance was reaffirmed: return to organic sales growth and slight improvement in organic Current Operating Margin.
Q3 group sales are expected to be broadly flat year on year, followed by Q4 reacceleration; EMEA weakness and measured China destocking weigh on Q3.
Expected tariff impact is €5m versus €20m previously, with no US impact and €5m in China; the ~€15m reduction will be reinvested to support growth.
FY currency impact is forecast at +€15m on sales and +€3m to +€5m on Current Operating Profit.
Latest events from Rémy Cointreau
- Q1 organic sales up 1.3%, driven by Cognac and APAC, with guidance reaffirmed.RMC
Q1 2027 TU - Organic sales up 0.2%, profit down, RC Forward targets €100m value by 2029.RMC
H2 25/26 - Q4 organic sales up 8.9%, led by Cognac in China, with cautious full-year outlook.RMC
Q4 2026 TU - Q3 organic sales rose 2.8% as US and EMEA gains offset APAC and China declines; guidance steady.RMC
Q3 2026 TU - Sales and profit margins fell, but transformation and investment in recovery continue.RMC
H1 25/26 - Sales and profit fell sharply, but margins held firm due to aggressive cost controls.RMC
H1 24/25 - Q1 sales dropped 15.6% organically, with gradual recovery and cost controls underway.RMC
Q1 24/25 TU - Sales and profit dropped, but cost savings and recovery with high single-digit growth are targeted.RMC
H2 23/24 - Q3 organic sales dropped 21.5%, but guidance and margin targets are maintained.RMC
Q3 24/25 TU